We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Michelle Lumasag has been assisting clients through the H1B Visa process since 2023.

As of 2022, Michelle Lumasag has succesfully submitted and recieved certification for 350 cases.

Michelle Lumasag is located in San Jose, CA, and has represented 5 employers for the H1B Visa Process

354
Cases Handled
350
Cases Certified
98.87%
Approval

Cases Handled by Michelle Lumasag

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-22311-573697 Certified Computer And Information Systems Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-22307-568513 Certified Computer And Information Systems Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-22287-531604 Certified Computer And Information Systems Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23150-061704 Certified Computer And Information Systems Managers Other Electronic Parts And Equipment Merchant Wholesalers Samsung Semiconductor Inc 2023
I-200-23129-005666 Certified Computer And Information Systems Managers Other Electronic Component Manufacturing Keysight Technologies Inc 2023
I-203-22333-610077 Certified Marketing Managers Research And Development In Biotechnology Except Nanobiotechnology Kite Pharma Inc 2023
I-200-23056-803636 Certified Marketing Managers Research And Development In Biotechnology Except Nanobiotechnology Kite Pharma Inc 2023
I-200-23055-802919 Certified Marketing Managers Research And Development In Biotechnology Except Nanobiotechnology Kite Pharma Inc 2023
I-200-22349-642105 Certified Marketing Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-22298-548016 Withdrawn Marketing Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023